K, K., & A, R. (2024). Clinical Utility of Various Formulations of Calcipotriene and Betamethasone Dipropionate for the Treatment of Plaque Psoriasis in Patients Aged 12 Years or Older. Drug Design, Development and Therapy, ume 18, 5827-5839.
Chicago-referens (17:e uppl.)K, Kędra, och Reich A. "Clinical Utility of Various Formulations of Calcipotriene And Betamethasone Dipropionate for the Treatment of Plaque Psoriasis in Patients Aged 12 Years or Older." Drug Design, Development and Therapy ume 18 (2024): 5827-5839.
MLA-referens (9:e uppl.)K, Kędra, och Reich A. "Clinical Utility of Various Formulations of Calcipotriene And Betamethasone Dipropionate for the Treatment of Plaque Psoriasis in Patients Aged 12 Years or Older." Drug Design, Development and Therapy, vol. ume 18, 2024, pp. 5827-5839.
